Your browser doesn't support javascript.
loading
Decoding the endometrial niche of Asherman's Syndrome at single-cell resolution.
Santamaria, Xavier; Roson, Beatriz; Perez-Moraga, Raul; Venkatesan, Nandakumar; Pardo-Figuerez, Maria; Gonzalez-Fernandez, Javier; Llera-Oyola, Jaime; Fernández, Estefania; Moreno, Inmaculada; Salumets, Andres; Vankelecom, Hugo; Vilella, Felipe; Simon, Carlos.
Afiliação
  • Santamaria X; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain. xsantamaria@fundacioncarlossimon.com.
  • Roson B; Department Ob/Gyn Vall d'Hebron Institut de Recerca, Barcelona, Spain. xsantamaria@fundacioncarlossimon.com.
  • Perez-Moraga R; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Venkatesan N; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Pardo-Figuerez M; Igenomix R&D, Valencia, Spain.
  • Gonzalez-Fernandez J; Department of Pediatrics Obstetrics & Gynecology, University of Valencia, Valencia, Spain.
  • Llera-Oyola J; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Fernández E; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Moreno I; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Salumets A; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Vankelecom H; Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
  • Vilella F; Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Simon C; Competence Centre on Health Technologies, Tartu, Estonia.
Nat Commun ; 14(1): 5890, 2023 09 21.
Article em En | MEDLINE | ID: mdl-37735465
Asherman's Syndrome is characterized by intrauterine adhesions or scarring, which cause infertility, menstrual abnormalities, and recurrent pregnancy loss. The pathophysiology of this syndrome remains unknown, with treatment restricted to recurrent surgical removal of intrauterine scarring, which has limited success. Here, we decode the Asherman's Syndrome endometrial cell niche by analyzing data from over 200,000 cells with single-cell RNA-sequencing in patients with this condition and through in vitro analyses of Asherman's Syndrome patient-derived endometrial organoids. Our endometrial atlas highlights the loss of the endometrial epithelium, alterations to epithelial differentiation signaling pathways such as Wnt and Notch, and the appearance of characteristic epithelium expressing secretory leukocyte protease inhibitor during the window of implantation. We describe syndrome-associated alterations in cell-to-cell communication and gene expression profiles that support a dysfunctional pro-fibrotic, pro-inflammatory, and anti-angiogenic environment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article